BHST (BioHarvest Sciences) FCF Margin % : -34.73% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioHarvest Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioHarvest Sciences's Free Cash Flow for the three months ended in Sep. 2024 was $-2.27 Mil. BioHarvest Sciences's Revenue for the three months ended in Sep. 2024 was $6.54 Mil. Therefore, BioHarvest Sciences's FCF Margin % for the quarter that ended in Sep. 2024 was -34.73%.

As of today, BioHarvest Sciences's current FCF Yield % is -9.09%.

The historical rank and industry rank for BioHarvest Sciences's FCF Margin % or its related term are showing as below:

BHST' s FCF Margin % Range Over the Past 10 Years
Min: -1022.68 Med: -296.04 Max: -44.68
Current: -44.68

During the past 10 years, the highest FCF Margin % of BioHarvest Sciences was -44.68%. The lowest was -1022.68%. And the median was -296.04%.

BHST's FCF Margin % is ranked worse than
92.66% of 1895 companies
in the Consumer Packaged Goods industry
Industry Median: 2.17 vs BHST: -44.68

BioHarvest Sciences FCF Margin % Historical Data

The historical data trend for BioHarvest Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences FCF Margin % Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,022.22

-401.24

-190.92

-78.88

BioHarvest Sciences Quarterly Data
	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-44.30	-72.68	-33.68	-44.23	-34.73

Competitive Comparison of BioHarvest Sciences's FCF Margin %

For the Packaged Foods subindustry, BioHarvest Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioHarvest Sciences's FCF Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's FCF Margin % falls into.

BioHarvest Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioHarvest Sciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-9.996	/	12.672
	=	-78.88 %

BioHarvest Sciences's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-2.271	/	6.539
	=	-34.73 %

BioHarvest Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (NAS:BHST) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

8MV0:Germany BHSC:Canada

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.